2010～2014年吉林大学中日联谊医院呼吸系统药物使用分析

Analysis of the Respiratory Systemdrugs in China-Japan Union Hospital of Jinlin University during 2010-2014

目的：评价呼吸系统药物临床应用现状与趋势。方法：回顾性统计吉林大学中日联谊医院HIS系统中2010-2014年呼吸系统药物的使用金额、数量、品规等数据,对用药金额、用药结构和用药特点等进行分析。结果：呼吸系统药物使用金额逐年增长,各亚类药物中平喘药、祛痰药、镇咳药使用频率保持稳定,其中平喘药占70%以上,细辛脑和多索茶碱一直排名前两位;祛痰药占20%左右,以黏痰溶解剂氨溴索和溴己新为主;镇咳药占1%左右,以中枢性镇咳药可待因为主;中成药使用比例小于10%。结论：呼吸系统药物的用药结构和用药特点保持稳定,用药金额在总金额中的比例增长幅度很小,变化不大,亚类药物中平喘药使用比例最大。

Objective： To evaluate the status and trends of respiratorysystem drugsclinical application in ahospital. Methods： By retrospective study, collected respiratory drugs amount, quantity, gauge and other data in China-Japan Union Hospital of Jinlin University HIS system from 2010 to 2014. The amount of money, structure and characteristics of drugs use were analyzed. Results： The amount of moneyof respiratory system drugs increased year by year, all the drugs in the antiasthmatic and expectorant, antitussive drug use frequency is stable, antiasthmatic accounted for more than 70%, Asarone and Doxofylline has been in the top two; About 20% expectorant, Phlegm solute is the main, including ambroxol and bromhexine; Cough drug accounted for 1%, mainly central cough drug codeine; the use ratio of proprietary Chinese drug is less than 10%. Conclusion： The proportion of respiratory system drugs amount of money in the total amountis basically stable, growth is very small, the structure and features of drugs use is stable, the usage of antiasthmatic is the biggest of all.